Literature DB >> 10648124

Interleukin-10 reduces natural killer (NK) sensitivity of tumor cells by downregulating NK target structure expression.

T Tsuruma1, A Yagihashi, K Hirata, T Torigoe, J Araya, N Watanabe, N Sato.   

Abstract

We examined the effect of exogenous IL-10 on the sensitivity of rat W14 and W31 tumor cells to natural killer (NK) cell-mediated cytotoxicity in relation to previously identified NK target structure (NKTS) expressed on these cells. We also examined the effect of endogenous interleukin-10 (IL-10) on rat IL-10 cDNA-introduced W31 cells (W31T-H, a high-IL-10-producer clone; W31T-L, a low-IL-10-producer clone). Both exogenous and endogenous IL-10 had no effect on the proliferative activity of these cells, but incubation of cells with recombinant human (rh) IL-10 resulted in a dose-dependent decrease in the expression of NKTS recognized by mAb 109. The expression level of NKTS on W31T-H cells was dramatically decreased compared with that on W31T-L cells and parental W31 cells. In addition, treatment of W31 cells with the culture supernatants of W31T-H cells could downregulate the expression of the NKTS. Moreover, NK sensitivity of W31T-H was suppressed down to a level equivalent to that of W31 cells pretreated with exogenous rhIL-10, and cytolysis could no longer be inhibited by mAb 109. We previously demonstrated that IL-10 downregulated MHC class I expression in this model. Nevertheless, NK susceptibility was also decreased. Taken together, these results suggest that the IL-10-mediated decrease in NKTS expression has a larger effect than decreased MHC class I expression on NK sensitivity. Thus, our data reveal a novel mechanism for an IL-10-mediated escape of tumor cells from host immune surveillance by downregulation of NKTS expression. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10648124     DOI: 10.1006/cimm.1999.1586

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

Review 1.  Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Authors:  Alessandro Allegra; Marco Casciaro; Elena Lo Presti; Caterina Musolino; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2022-05-27

2.  Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma.

Authors:  M Watanabe; K Kono; Y Kawaguchi; Y Mizukami; K Mimura; T Maruyama; H Fujii
Journal:  Br J Cancer       Date:  2009-12-22       Impact factor: 7.640

3.  Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.

Authors:  Tim D Eubank; Ryan D Roberts; Mahmood Khan; Jennifer M Curry; Gerard J Nuovo; Periannan Kuppusamy; Clay B Marsh
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 4.  Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.

Authors:  Gianfranco Pittari; Luca Vago; Moreno Festuccia; Chiara Bonini; Deena Mudawi; Luisa Giaccone; Benedetto Bruno
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561

5.  CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.

Authors:  Wei Hseun Yeap; Kok Loon Wong; Noriko Shimasaki; Esmeralda Chi Yuan Teo; Jeffrey Kim Siang Quek; Hao Xiang Yong; Colin Phipps Diong; Antonio Bertoletti; Yeh Ching Linn; Siew Cheng Wong
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.